Jalra-M 50mg/1000mg Tablet 
Bookmark
NOTICE: unsafe with : Alcohol
USED FOR:
Type 2 diabetes
COMPOSITION:
Metformin (1000mg) + Vildagliptin (50mg)
Therapeutic Uses:
anti diabetic
CAUTION
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
WEIGH RISKS VS BENEFITS
Jalra-M 50mg/1000mg Tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Jalra-M 50mg/1000mg Tablet during lactation. Please consult your doctor.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
CAUTION
Jalra-M 50mg/1000mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jalra-M 50mg/1000mg Tablet may be needed. Please consult your doctor.
CAUTION
Jalra-M 50mg/1000mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jalra-M 50mg/1000mg Tablet may be needed. Please consult your doctor.Regular monitoring of liver function tests is recommended if you are taking this medicine. Use of $med_name is preferably not advised in patients with liver disease.
Uses of Jalra-M Tablet
Jalra-M 50mg/1000mg Tablet is used in the treatment of type 2 diabetes.
How to use Jalra-M Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jalra-M 50mg/1000mg Tablet is to be taken with food.Jalra-M 50mg/1000mg Tablet may cause stomach upset if taken on empty stomach.
How Jalra-M Tablet works
Jalra-M 50mg/1000mg Tablet is a combination of two antidiabetic medicines: Metformin and vildagliptin. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Vildagliptin is a dipeptidyl peptidase-4 inhibitor which works by increasing the release of insulin from pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.
Common Nausea, Altered taste, Stomach pain, Diarrhoea, Loss of appetite, Dizziness, Headache, Shivering, Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea.
ABOUT US
Medical Network Pvt. Ltd. offers trusted and user-friendly online pharmacy and healthcare services, providing quality medicines and healthcare solutions.
What our customer says
Sri M.
Jalandhar
M.Apte
Mumbai
J.Singh
New Delhi
M.Kaur
Chandigarh
T.Yadav
Patna
